peritoneal dialysis

Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model

Zhang P, Miyata KN, Nast CC, LaPage JA, Mahoney M, Nguyen S, Khan K, Wu Q, Adler SG, Dai T. Dual therapy with an angiotensin[...]

By sjmartinez • April 5, 2023

Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: A Standardised Outcomes in Nephrology-Peritoneal Dialysis consensus workshop report

Cheetham MS, Wilkie M, Loud F, Manera KE, Ju A, Figueiredo A, Farragher J, Hurst H, Jassal SV, Mehrotra R, Morton RL, Schwartz D, Shen[...]

By sjmartinez • November 9, 2022